Breast tumor with giant borderline phyllodes: Case report and literature review

乳腺肿瘤伴巨大交界性叶状肿瘤:病例报告及文献综述

阅读:1

Abstract

RATIONALE: Giant phyllodes tumors are rare fibroepithelial neoplasms, accounting for less than 1% of all primary breast tumors. Their main features are a single-round mass, progressive enlargement, and a high rate of local recurrence. A phyllodes tumor measuring more than 10 cm in diameter is usually defined as a "giant" tumor. Surgery remains the primary treatment option, although the efficacy of adjuvant radiotherapy needs to be confirmed by further studies. PATIENT CONCERNS: We report a rare case involving a 38-year-old woman who presented, in May 2022, with a large, borderline lobulated tumor in her left breast, measuring 35 cm × 30 cm. She needed to physically support the mass when performing any activity, and even slight physical activity elevated her heart rate to 130 beats/min. In addition, the patient was unable to lie flat and could only sleep on her left side. DIAGNOSES: Breast B-ultrasound examination and chest computed tomography scans showed the possibility of inflammatory changes. Ultrasound-guided pathologic examination of the mass could not determine the type of mass. Immunofluorescence and bacterial culture of the aspirated fluid were also negative, ruling out the possibility of infection. A mastectomy was then performed to clarify the diagnosis. INTERVENTIONS: The tumor was completely removed, and the patient did not receive any adjuvant therapy after surgery. OUTCOMES: The patient recovered smoothly. Unfortunately, she experienced a recurrence of the left breast mass six months later, which progressed to malignancy. LESSONS: The most effective treatment for phyllodes tumors of breast is wide local excision with clean margins greater than 1 cm. Simple mastectomy is recommended for borderline or malignant cases, especially when it is difficult to achieve reliable negative margins. Although adjuvant radiotherapy and chemotherapy after surgery are not generally recommended as first-line treatments, it raises the question of whether the recurrence could have been delayed if the patient had received postoperative radiation therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。